Koyfin Home > Directory > Health Care > Arcus Biosciences Inc > Cash from Financing Activities

Arcus Biosciences Inc Cash from Financing Activities Chart (RCUS)

Arcus Biosciences Inc annual/quarterly Cash from Financing Activities from 2017 to 2018.
  • Arcus Biosciences Inc Cash from Financing Activities for the quarter ending December 12, 2018 was $1m a -16,687.03% decrease of -129m year over year
  • Arcus Biosciences Inc Cash from Financing Activities for the last 12 months ending December 12, 2018 was $129m a -83.46% decrease of -108m year over year
  • Arcus Biosciences Inc Annual Cash from Financing Activities for 2018 was $129m a 16.80% increase of 22m from 2017
  • Arcus Biosciences Inc Annual Cash from Financing Activities for 2017 was $107m a 34.73% increase of 37m from 2016
  • Arcus Biosciences Inc Annual Cash from Financing Activities for 2016 was $70m
Other Cash Flow Metrics:
  • Arcus Biosciences Inc Cash Flow from Operations for the quarter ending December 12, 2018 was $-7m a -86.39% increase of 6m year over year
  • Arcus Biosciences Inc Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $-5m
  • Arcus Biosciences Inc Total Revenue for the quarter ending December 12, 2018 was $2m a 19.97% increase of 0m year over year
View Chart On Koyfin

Quarterly RCUS Cash from Financing Activities Data

12/2018$1m
09/2018$0m
06/2018$-1m
03/2018$129m
12/2017$107m
09/2017$0m
06/2017$1m
03/2017$0m

Annual RCUS Cash from Financing Activities Data

2018$129m
2017$107m
2016$70m